JFGIW
CAPR icon

Johnson Financial Group Inc (Wisconsin)’s Capricor Therapeutics CAPR Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
1
– – ﹤0.01% 805
2026
Q1 		$31 Buy
+1
New +$27 ﹤0.01% 875

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s CAPR Position: Q2 2026 in Review

Johnson Financial Group Inc (Wisconsin) held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 1 share worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #805.

Johnson Financial Group Inc (Wisconsin) first reported a position in CAPR in Q1 2026 and has held it in 2 quarters since. The position peaked at $31 in Q1 2026. 169 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • Johnson Financial Group Inc (Wisconsin) held 1 share of Capricor Therapeutics worth $25 as of Q2 2026.
  • Johnson Financial Group Inc (Wisconsin) left its Capricor Therapeutics share count unchanged in Q2 2026.
  • Capricor Therapeutics made up ﹤0.01% of Johnson Financial Group Inc (Wisconsin)'s portfolio in Q2 2026, its #805 holding.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Capricor Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Johnson Financial Group Inc (Wisconsin)'s Capricor Therapeutics position peaked at $31 in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q2 2026, filed 10 Aug 2026.